Drug Supply, Trade and Channel Management – Insights
Your year-round hub for insights into pharmaceutical trade, distribution and channel strategies - helping you navigate shifting markets, master compliance and scale for growth.
This hub is your go-to resource for navigating the evolving world of pharmaceutical trade, distribution and channel management. From regulatory updates to real-world strategy insights, we bring you the knowledge, tools and perspectives you need to deliver market access and growth in a rapidly shifting healthcare landscape.
Session Spotlights
Explore in-depth discussions from leading voices in pharmaceutical trade, distribution and channel strategy. Each spotlight captures the most relevant ideas, case studies and practical takeaways from across the industry - from optimizing pharma supply chain and distribution networks, to strengthening pharmacy channels, advancing drug commercialization and enhancing global trade readiness.
Whether you’re looking to master compliance, streamline pharmacy distribution or build stronger partnerships with pharmacy stakeholders and health systems, these sessions deliver real-world strategies you can apply year-round to drive market access, innovation, and growth.
Building the Blueprint – Designing Effective Distribution Networks for New Products
When introducing a new therapy to the market, the design of your distribution network can make or break your success. This session explores the strategic considerations that ensure your pharma supply chain and distribution model supports both patient access and commercial performance. From assessing product-specific requirements to aligning stakeholders, you’ll gain a framework to build a distribution strategy that drives market access and sustainable growth.
Topic Area: Pharmacy Models
DSCSA Serialization – Real-World Applications and Challenges in the Post-Implementation Era
With the Drug Supply Chain Security Act (DSCSA) now fully implemented, pharmaceutical manufacturers, distributors and pharmacy stakeholders are navigating a new era of product traceability. This session examines how serialization is impacting pharma supply chain and distribution operations, from compliance to competitive advantage. Beyond meeting regulatory requirements, serialization offers an opportunity to enhance inventory management, protect patients and strengthen pharmacy distribution networks worldwide.
Topic Area: Pharma Supply Chain, Distribution, and Logistics
Transforming Healthcare Partnerships Through AI and Digital Integration
Digital innovation is redefining how pharmaceutical companies and health systems collaborate to improve patient outcomes. By integrating AI with multiple digital touchpoints, from telehealth platforms and patient portals to remote monitoring tools and EHR systems, organizations can streamline care delivery, strengthen pharmacy stakeholder relationships and enhance market access strategies. This session explores how AI-driven solutions are creating more efficient, personalised and connected healthcare ecosystems.
Topic Area: Health Systems & Pharma Partnering
Your Questions Answered: Drug Commercialization & Pharmacy Channels
What are the key trends in pharma supply chain and distribution?
The pharmaceutical supply chain is evolving with digital integration, AI-driven analytics and network design. Stakeholders are focusing on efficiency, compliance and resilience to adapt to market access challenges and global trade disruptions.
How does market access impact drug commercialization?
Market access strategies determine how quickly and effectively a drug reaches patients. By aligning distribution networks, pharmacy channels and stakeholder engagement, companies can improve uptake and optimize revenue potential.
What should be considered when designing pharmacy distribution networks?
Effective pharmacy distribution requires evaluating product handling needs, patient access requirements, regulatory compliance and coordination across pharmacy stakeholders. Tailoring the network ensures both operational efficiency and successful market penetration.
How is global trade affecting pharmaceutical distribution?
International regulations, tariffs and logistics challenges influence how drugs are transported and stored. Companies must adapt supply chain strategies to maintain compliance and ensure uninterrupted delivery to pharmacies and health systems worldwide.
What role do pharmacy stakeholders play in supply chain management?
Pharmacy stakeholders, including manufacturers, distributors, specialty pharmacies and health systems, collaborate to manage inventory, optimize channels and support patient access. Clear roles and communication are critical to maintain efficiency and compliance.
What are pharmacy channels and why are they important?
Pharmacy channels refer to the pathways through which drugs reach patients, such as retail, specialty or hospital pharmacies. Optimizing these channels ensures timely delivery, maximizes market access and improves patient outcomes.
How can AI and digital tools improve pharmacy operations?
AI and digital integration streamline inventory management, enhance decision-making and support patient-centric care. They also enable better collaboration between pharma companies and pharmacy stakeholders, creating more agile and responsive supply chains.
How does DSCSA serialization affect pharmacy distribution?
Serialization strengthens supply chain integrity, prevents counterfeiting and ensures traceability of drugs from manufacturer to patient. It’s a key component of pharmacy distribution strategy and compliance in both domestic and global markets.